Switzerland · Funded startup

Who invested in Limula

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$566Kraised across 1 round since 2024, from 1 source

Latest round
Debt, $566KDec 2024
Investors
4
See who backed them

The rounds

  1. Dec 2024

Founders and team

From Limula's own website: 2 founders, 3 on the team.

Thomas EatonFounder and CEO
Yann PiersonFounder and CTO
  • Caroline BoudousquiéHead of Solutions
  • Olivier WaridelHead of Operations
  • Dr. Oliver DickBoard of Directors

Everyone who backed them

MassChallengeAccelerator1round
EIC AcceleratorGovernment1round
Venture KickAccelerator1round
Verve VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Limula as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

LifeX VenturesVC firmPer its own site
Lichtsteiner FoundationFamily officePer its own site

Quick answers about Limula

Who invested in Limula?

Limula's investors include MassChallenge, EIC Accelerator, Venture Kick and Verve Ventures.

How much has Limula raised?

Limula has raised $566K across 1 round since 2024.

When did Limula last raise?

Limula's most recent round was a Debt of $566K in Dec 2024.

What was Limula's biggest round?

Its most recent round, $566K in Dec 2024, is also its largest on record.

Who backed Limula first?

Limula's first round on record, in Dec 2024, was backed by MassChallenge, EIC Accelerator and Venture Kick and 1 others.

What stage is Limula at?

Limula's latest named round is a Debt, in Dec 2024.

Where is Limula based?

Limula is based in Switzerland.

Companies like Limula

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.